Clinical trial data: to disclose or not to disclose?

@article{Bouchie2006ClinicalTD,
  title={Clinical trial data: to disclose or not to disclose?},
  author={Aaron J. Bouchie},
  journal={Nature Biotechnology},
  year={2006},
  volume={24},
  pages={1058-1060}
}
On August 3, US Senators Enzi (R-WY) and Kennedy (D-MA) introduced legislation, which, if enacted, could help bolster the public’s confidence in the drug industry and the government agency that regulates it. The bill, called The Enhancing Drug Safety and Innovation Act of 2006 (S. 3807), calls for the establishment of a mandatory clinical trials registry and results database. In requiring that outcomes be included, such a registry differs significantly from the existing government database… CONTINUE READING